Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajib Bhattacharya

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Urology|August 25, 2015
Editorial CommentRajib Bhattacharya
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 2, 2005
Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trialSusan L Greenspan, Thomas J Beck, Neil M Resnick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2008
Risedronate prevents bone loss in breast cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trialSusan L Greenspan, Adam Brufsky, Barry C Lembersky, et al.
Indian Journal of Endocrinology and Metabolism|December 30, 2017
Bhagavad Gita for the PhysicianSanjay Kalra, Ameya Joshi, Bharti Kalra, et al.
The Journal of Clinical Endocrinology and Metabolism|January 30, 2026
Heart ventricular function in hospitalized patients with severe hypothyroidism and myxedema comaJoaquin Lado-Abeal, Irsa Munir, Khalid Al-Zubaidi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Urology|August 25, 2015
Editorial CommentRajib Bhattacharya
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 2, 2005
Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trialSusan L Greenspan, Thomas J Beck, Neil M Resnick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2008
Risedronate prevents bone loss in breast cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trialSusan L Greenspan, Adam Brufsky, Barry C Lembersky, et al.
Indian Journal of Endocrinology and Metabolism|December 30, 2017
Bhagavad Gita for the PhysicianSanjay Kalra, Ameya Joshi, Bharti Kalra, et al.
The Journal of Clinical Endocrinology and Metabolism|January 30, 2026
Heart ventricular function in hospitalized patients with severe hypothyroidism and myxedema comaJoaquin Lado-Abeal, Irsa Munir, Khalid Al-Zubaidi, et al.
Pageof 1